Back
Mirati Therapeutics Stock Predictions

Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
53
MRTX
Mirati Therapeutics
Last Price:
52.56
Seasonality Move:
-5.31%
7 Day Trial
ALL ACCESS PASS
$
7

Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!Mirati Therapeutics Stock Forecast
- Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 59.4% based on the past 9 years of stock performance.
- Mirati Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Mirati Therapeutics Stock Undervalued?
The current Mirati Therapeutics [MRTX] share price is $52.57. The Score for MRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal. - MRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Mirati Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Mirati Therapeutics has on average historically risen by 59.4% based on the past 9 years of stock performance.
Mirati Therapeutics Stock Rating
Buy
53
Mirati Therapeutics (MRTX)
is a Buy
Is Mirati Therapeutics overpriced?
- Mirati Therapeutics has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Mirati Therapeutics Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
mirati.com
52-Week Data
52-Week High:
124.81
52-Week Low:
32.96
Prediction Charts
Market Cap:
3.03B
Price in USD:
52.57
Volume:
1.01M
Beta:
1.23
Technical Analysis
SMA50:
54.31
SMA100:
61.89
SMA200:
64.16
52-Wk Change:
-55.39%
Stock Predictions
-
Is Mirati Therapeutics stock public?
Yes, Mirati Therapeutics is a publicly traded company. -
What is the Mirati Therapeutics stock quote today?
The Mirati Therapeutics stock price is 52.57 USD today. -
How to buy Mirati Therapeutics stock online?
You can buy Mirati Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-17 | 42.38 | 44.00 | 44.19 | 41.45 |
Jan-18 | 44.66 | 44.69 | 45.28 | 43.95 |
Jan-19 | 44.69 | 42.98 | 44.69 | 42.44 |
Jan-20 | 43.40 | 45.66 | 45.80 | 42.93 |
Jan-23 | 46.05 | 47.91 | 48.59 | 45.51 |
Jan-24 | 47.57 | 49.36 | 50.62 | 46.76 |
Jan-25 | 48.59 | 49.22 | 49.25 | 47.55 |
Jan-26 | 49.74 | 51.06 | 51.35 | 48.88 |
Jan-27 | 50.73 | 53.09 | 53.60 | 50.73 |
Jan-30 | 52.80 | 51.81 | 53.99 | 51.13 |
Jan-31 | 52.25 | 53.41 | 55.29 | 52.24 |
Feb-1 | 53.47 | 52.69 | 53.47 | 49.39 |
Feb-2 | 53.66 | 54.26 | 55.15 | 52.95 |
Feb-3 | 53.11 | 52.57 | 53.55 | 51.62 |
Mirati Therapeutics Earnings
Mirati Therapeutics Earnings Report: Per Share Mirati Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Mirati Therapeutics Forecast Revenue Growth
Mirati Therapeutics Stock Analysis: Historical quarterly revenues per share for Mirati Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $2.53 per share.
* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.